Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, has announced its acquisition of Oncompass Medicine. Founded in Budapest in 2003, Oncompass Medicine has been a leader in personalized oncology for more than two decades. The company has supported patients and healthcare providers across Europe with advanced precision oncology services, pioneered some of the first companion diagnostic tests for precision oncology in 2003, and was among the first to implement next-generation sequencing-based tumor profiling in routine clinical care in 2008.
Read the full article: Genomate Health Expands Global Footprint with Acquisition of Oncompass Medicine //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/genomate-health-expands-global-footprint-with-acquisition-of-oncompas-1113068